ACL vs CBL

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

51MEDIUM

CBL

CTRLBIONIC FPO [CBL]

51MEDIUM

Score Breakdown

ACL CBL
Technical
51
63
Catalyst
71
61
Sentiment
50
50
Fundamental
68
46
Momentum
52
75
Risk Gate
36
50

Key Metrics

ACL Metric CBL
$433.7MMarket Cap$31.2M
575KAvg Volume (20d)571K
+6.5%Short InterestN/A
$2.97052-Week High$0.095
$1.83352-Week Low$0.032
+0.0%Daily Change+6.1%
$2.330Reference Price$0.070
+16.7%ROE-91.6%
+3.6%Profit Margin-107.0%

Active Signals

ACL Signals

Trading above both moving averages — the trend is your friend here
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
New substantial holder(s) (1)

CBL Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a green day — buyers stepping up
Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (3 quarters) - dilution risk

Ask Scout AI to compare ACL and CBL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CBL vs IDX →ACL vs IDX →ENP vs IPD →CBL vs ENP →ACL vs ENP →
ACL Full Analysis → CBL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).